Markers of hepatitis B virus infection in a subset of young people in central Nigeria

Date

2019-05-23

Journal Title

Journal ISSN

Volume Title

Publisher

DEPARTMENT OF MICROBIOLOGY, NASARAWA STATE UNIVERSITY, KEFFI.

Abstract

Hepatitis B virus (HBV) is 50–100 times more infectious than HIV, and hepatitis B is endemic in Nigeria. In this study, we evaluated the serologic markers of HBV infection and associated socio-demographic factors in a subset of young people in Central Nigeria . Blood samples were collected from 350 consenting newly admitted students of the 2016/2017 academic session of Nasarawa State University, and their socio-demographic information obtained using structured questionnaires. The sera were analysed for HBsAg, HBsAb, HBcAb, HBeAg and HBeAb using a 5-panel HBV profiling diagnostic kits (Qingdad High Top Biotech Co. Ltd, Hangzhou, China). Data was analysed using Smith’s Statistical Package (version 2.80, California, USA); and test of significance performed at 95% confidence limit with P values ≤0.05 considered significant. Of the 350 participants, 157 (44.9%) were male and 193 (55.1%) were female. Overall, 34 (9.7%) had HBsAg, 134 (38.3%) had HBsAb, 98 (28.0%) had HBcAb, 13 (3.7%) had HBeAg and 16 (4.6%) had HBeAb. Gender distribution showed that 20 (12.7%), 78 (49.7%), 59 (37.6%), 9 (5.7%) and 11 (7.0%) of male subjects had HBsAg, HBsAb, HBcAb, HBeAg and HBeAb respectively. Among female subjects, the distribution of HBsAg, HBsAb, HBcAb, HBeAg and HBeAb was 14 (7.3%), 56 (29.0%), 39 (20.2%), 4 (2.1%) and 5 (2.6%), respectively. Being male, unmarried and histories of alcohol consumption, blood transfusion, sharing of sharp objects and multiple sex partners were significant predictors of infection ( p ˂ 0.05). This study reveals high prevalence of HBV and risk of transmission in the apparently healthy freshmen. Our findings have critical implications for intervention initiatives especially among students and youths.

Description

Keywords

Hepatitis B virus Hepatitis B core antibody Hepatitis B e antigen Hepatitis B surface antibody Hepatitis B e antibody Nigeria

Citation

[1] M.P. Adoga , E.B. Banwat , J.C. Forbi , L. Nimzing , C.R. Pam , S.D. Gyar , Y.A. Agabi , S.M. Agwale , Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa state, Nigeria, J. Infect. Dev. Ctries. 3 (7) (2009) 539–547 . [2] M.P. Adoga , S.D. Gyar , S. Pechulano , O.D. Bashayi , S.E. Emiasegen , T. Zungwe , O.H. Iperepolu , C. Agupugo , S.M. Agwale , Hepatitis B virus infections in apparently healthy urban nigerians: data from pre-vaccination tests, J. Infect. Dev. Ctries. 4 (6) (2010) 397–400 . [3] M.P. Adoga , G. Pennap , B.O. Akande , J.P. Mairiga , S. Pechulano , S.M. Agwale , Evaluation of a recombinant DNA hepatitis B vaccine in a vaccinated Nigerian population, J. Infect. Dev. Ctries. 4 (11) (2010) 740–744 . [4] J.C. Forbi, G. Vaughan, M.A. Purdy, D.S. Campo, G.L. Xia, L.M. Ganova-Raeva, S. Ramachandran, H. Thai, Y.E. Khudyakov, Epidemic history and evolu- tionary dynamics of hepatitis B virus infection in two remote communities in rural Nigeria, PLoS One 5 (7) (2010) e11615, doi: 10.1371/journal.pone. 0011615 . [5] B.V. Oti , G.R. Pennap , H.R. Ngari ,HBsAg and anti-HCV prevalence among pregnant women accessing antenatal care in a tertiary healthcare facility in central nigeria, Hepatol. Pan. Sci. 2 (2018) 110–113 . [6] C.L. Thio, C.A. Hawkins, Hepatitis b virus and hepatitis delta virus, Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases, 8th ed., Elsevier Inc, 2014, pp. 1815–1839. e7, doi: 10.1016/B978- 1- 4557- 4801- 3.00148- X .

Collections